May 31, 2018
Arix Biosciences director steps down
Arix Bioscience’s Non-Executive Director Lord Hutton is stepping down from his position, Arix said Thursday.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Approval
May 31, 2018
Boehringer Ingelheim’s Gilotrif dose adjustments helped improve patient tolerability in certain lung cancer
Boehringer Ingelheim’s study showed that dose adjustment with Gilotrif helped improve patient tolerability while maintaining treatment efficacy and reduced the frequency…
May 31, 2018
FDA approves new treatment for moderately to severely active ulcerative colitis
The U.S. Food and Drug Administration today expanded the approval of Pfizer’s Xeljanz (tofacitinib), the first oral medication approved for…
May 30, 2018
Hikma launches Methylergonovine Maleate tablets
Hikma Pharmaceuticals said that its wholly-owned US subsidiary, West-Ward Pharmaceuticals Corp. has launched Methylergonovine Maleate Tablets, USP, 0.2mg, the generic…
May 30, 2018
China Drug Administration approves Gilead’s chronic hepatitis C virus infection drug
Gilead Sciences has gotten the approval from the China Drug Administration (CDA) of Epclusa for the treatment of adults with…
May 30, 2018
FDA expedites review of Novartis drug Promacta for first-line severe aplastic anemia
Novartis said Tuesday that the US Food and Drug Administration (FDA) has accepted the its supplemental New Drug Application (sNDA)…
May 30, 2018
Allergan recalls pregnancy prevention pills due to out of sequence capsules
Allergan is recalling one lot of Taytulla physicians sample pack, indicated for use by women to prevent pregnancy, because of…
May 30, 2018
AstraZeneca’s COPD drug failed to meet the primary endpoint
AstraZeneca and MedImmune, said that the trial Terranova, the second of two pivotal Phase III trials for Fasenra (benralizumab) in patients…
May 29, 2018
FDA accepts larotrectinib Bayer’s New Drug Application and grants priority review
The U.S. Food and Drug Administration (FDA) has accepted Bayer’s partner’s Loxo Oncology’s New Drug Application (NDA), and granted Priority…
May 29, 2018
Novartis reports significant improvement in symptom frequency and quality of life domains with Entresto
Novartis has gotten new evidence from the CHAMP-HF registry comparing Entresto patients to patients not taking Entresto, which showed that…